Skip to main content

Table 1 Epidemiological studies of the associated risk between dyslipidemia and venous thromboembolism (VTE)

From: The role of dyslipidemia and statins in venous thromboembolism

       Prevalence  
       of lipid Odds
   Mean age   % cases   risk factor ratio
  No. cases/ of cases VTE with situational   among (95% CI)
Study [reference] controls (years) type risk factors* Serum lipid risk factor(s) cases (%) for VTE
Goldhaber et al [7] 280/112542 30–55 PE 55 Self-reported elevated TC 18 1.1 (0.7–1.5)
Kawasaki et al [8] 109/109 50 Leg DVT 34 TC > 5.7 mmol/L and TG > 1.7 mmol/L 23 5.1 (2.0–13.0)
      TC > 5.7 mmol/L and TG ≤ 1.7 mmol/L 26 2.6 (1.2–5.3)
Nowak-Gottl et al [10] 186/186 5 Any VTE 60 Lp(a) > 30 mg/dL 42 7.2 (3.7–14.5)
von Depka et al [11] 685/266 34 Any VTE 21 Lp(a) > 10 mg/dL 40 1.6 (1.2–2.2)
      Lp(a) > 20 mg/dL 25 2.2 (1.5–3.3)
      Lp(a) > 30 mg/dL 20 3.2 (1.9–5.3)
  1. *Defined as either immobilization (i.e. trauma, surgery, or bedridden) or presence of an indwelling venous catheter at the site of thrombosis. DVT = deep vein thrombosis; Lp(a) = lipoprotein (a); PE = pulmonary embolism; TC = total cholesterol; TG = triglycerides; VTE = venous thromboembolism.